NCT00653146

Brief Summary

RATIONALE: Mindfulness-based stress reduction (MBSR) may reduce patient stress and improve quality of life. It is not yet known whether mindfulness-based stress reduction is effective in improving immune response to human papillomavirus in patients with cervical dysplasia. PURPOSE: This randomized clinical trial is studying whether mindfulness-based stress reduction (MBSR) or a general diet and physical activity program has any effects on immune response to human papillomavirus in patients with cervical dysplasia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
186

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2007

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2007

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

April 3, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 4, 2008

Completed
6.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2014

Completed
Last Updated

December 5, 2016

Status Verified

December 1, 2016

Enrollment Period

6.8 years

First QC Date

April 3, 2008

Last Update Submit

December 1, 2016

Conditions

Keywords

cervical cancerpsychosocial effects of cancer and its treatmenthuman papilloma virus infectionatypical squamous cells of undetermined significancelow-grade squamous intraepithelial lesion

Outcome Measures

Primary Outcomes (1)

  • Comparison of indices of psychosocial well-being between the mindfulness-based stress reduction (MBSR) and control groups

    baseline, post-intervention, 6 months, and 12 months

Secondary Outcomes (3)

  • Comparison of the MBSR and control groups on measures of HPV-specific immune response

    baseline, post-intervention, 6 months, and 12 months

  • Correlation of variations in psychosocial factors (e.g., perceived stress, cancer-related distress, QOL) between treatment group (MBSR vs. attention control) and immunologic outcomes

    baseline, post-intervention, 6 months, and 12 months

  • Effect of treatment group and process variables on psychosocial well-being

    baseline, post-intervention, 6 months, and 12 months

Study Arms (2)

Mindfulness-based stress reduction

EXPERIMENTAL

The MBSR program includes meditation techniques, body scan, awareness of breathing, mindful yoga, eating meditation, and walking meditation, and meets for 2 hours, once weekly for 8 weeks.

Behavioral: Mindfulness-Based Stress Reduction

Healthy Lifestyles Program

PLACEBO COMPARATOR

The Healthy Lifestyles Program includes information on nutrition and physical activity, and meets for 2 hours, once weekly for 8 weeks.

Behavioral: Healthy Lifestyles

Interventions

In the intervention program, a variety of mindfulness meditation techniques will be taught, including the body scan, awareness of breathing, mindful yoga, eating meditation and walking meditation.

Also known as: MBSR
Mindfulness-based stress reduction

In the control condition, information on healthy lifestyles will be presented in a didactic fashion. Session topics include diet and nutrition, physical activity, and healthy behaviors to prevent cardiovascular disease and cancer.

Healthy Lifestyles Program

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
DISEASE CHARACTERISTICS: * Referred for a colposcopy following an abnormal Pap smear test result * Atypical squamous cells of undetermined significance/positive for human papilloma virus or mild to moderate dysplasia * Referred for a second opinion OR patient of record within the medical practice who is undergoing routine recommended follow-up * Recruited from Fox Chase Cancer Center or Thomas Jefferson University Hospital * No history of cervical cancer * No evidence of present invasive carcinoma PATIENT CHARACTERISTICS: * Must be able to read and/or communicate in English * Not pregnant * No known HIV positivity * No psychiatric disorder or other disorder that would preclude informed consent PRIOR CONCURRENT THERAPY: * Not specified

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (2)

Kimmel Cancer Center at Thomas Jefferson University - Philadelphia

Philadelphia, Pennsylvania, 19107-5541, United States

Location

Fox Chase Cancer Center - Philadelphia

Philadelphia, Pennsylvania, 19111-2497, United States

Location

MeSH Terms

Conditions

Uterine Cervical NeoplasmsPrecancerous ConditionsPapillomavirus InfectionsAtypical Squamous Cells of the CervixSquamous Intraepithelial Lesions

Interventions

Mindfulness-Based Stress Reduction

Condition Hierarchy (Ancestors)

Uterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesSexually Transmitted Diseases, ViralSexually Transmitted DiseasesCommunicable DiseasesInfectionsDNA Virus InfectionsVirus DiseasesTumor Virus InfectionsDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsUterine Cervical DysplasiaMorphological and Microscopic Findings

Intervention Hierarchy (Ancestors)

MindfulnessCognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Carolyn Fang, PhD

    Fox Chase Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 3, 2008

First Posted

April 4, 2008

Study Start

September 1, 2007

Primary Completion

July 1, 2014

Study Completion

July 1, 2014

Last Updated

December 5, 2016

Record last verified: 2016-12

Locations